55513-670Level 3
AVSOLA (infliximab-axxq)
**Product type:** Human Prescription Drug
**Active ingredient:** INFLIXIMAB
**Strength:** 100 mg/10mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Amgen, Inc
**Marketing category:** BLA (BLA761086)
**Pharmacologic class:** Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
GET
/api/v1/systems/ndc_fda/nodes/55513-670Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.